Fund Information / Factsheet • Sep 23, 2024
Fund Information / Factsheet
Open in ViewerOpens in native device viewer
Marketing Communication
| Share price performance | Performance over (%) |
6m | 1y | 3y | 5y | 10y | Commentary at a glance |
|---|---|---|---|---|---|---|---|
| (total return) Price (rebased) |
Share price (Total return) |
15.1 | 17.4 | 28.1 | 37.7 | 82.4 | Performance In the month under review the Company's NAV total |
| Benchmark NAV (cum income) 160 140 120 |
NAV (Total return) |
14.3 | 21.1 | 31.6 | 43.4 | 89.2 | return was 0.6% and the FTSE All-Share Index total return was 0.5%. |
| Benchmark (Total return) |
12.6 | 17.0 | 24.4 | 37.9 | 80.9 | Contributors/detractors The underweight position in Shell, which suffered from the weak oil price, was the biggest positive relative contributor to performance. The biggest detractor was the underweight position in AstraZeneca. |
|
| 100 80 60 |
Relative NAV (Total return) |
1.7 | 4.1 | 7.2 | 5.5 | 8.4 | |
| 40 20 0 Aug 19 Aug 20 Aug 21 Aug 22 Aug 23 Aug 24 |
Discrete year performance (%) |
Share price (total return) |
NAV (total return) |
Outlook We think the valuation of UK equities is compelling compared to their equivalents overseas, particularly the dividend yield which is attractive relative to the |
|||
| Dividend history | 30/6/2023 to 30/6/2024 |
11.3 | 15.6 | main alternatives. | |||
| (pence/share) 25.0 |
30/6/2022 to 30/6/2023 |
4.1 | 4.5 | See full commentary on page 3. | |||
| Income 20.0 |
30/6/2021 to 30/6/2022 |
7.7 | 7.5 | References made to individual securities do not constitute a recommendation to buy, sell or hold any security, investment strategy or market sector, and should not be assumed to be profitable. Janus |
|||
| 15.0 | 30/6/2020 to have a position in the securities mentioned. 21.3 20.0 30/6/2021 |
Henderson Investors, its affiliated advisor, or its employees, may | |||||
| 10.0 | 30/6/2019 to 30/6/2020 |
-16.2 | -14.6 | ||||
| 5.0 0.0 |
n/a n/a n/a All performance, cumulative growth and annual growth data is sourced from Morningstar. |
||||||
| 04 06 08 10 12 14 16 18 20 22 24 Please note that this chart could include dividends that have been |
Source: at 31/08/24. © 2024 Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or |
predict future returns.
Please remember that past performance does not predict future returns. The value of an investment and the income from it can rise as well as fall as a result of market and currency fluctuations, and you may not get back the amount originally invested. Please refer to the glossary for the definition of share price total return.
timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance does not
| How to invest | ||
|---|---|---|
declared but not yet paid.
Go to www.janushenderson.com/howtoinvest
Find out more Go to www.cityinvestmenttrust.com
The Company's objective is to provide long-term growth in income and capital, principally by investment in equities listed on the London Stock Exchange. The Board fully recognises the importance of dividend income to shareholders.
Renowned for its record-setting annual dividend increases since 1966, the Company targets longterm income and capital growth.
| NAV (cum income) | 445.0p |
|---|---|
| NAV (ex income) | 441.3p |
| Share price | 438.0p |
| Discount(-)/premium(+) | -1.6% |
| Yield | 4.7% |
| Net gearing | 10% |
| Net cash | - |
| Total assets | £2,345m |
| Net assets | £2,200m |
| Market capitalisation | £2,165m |
| Shares in issue excluding shares in Treasury |
494,334,723 |
| Total number of holdings | 82 |
| Ongoing charges (year end 30 Jun 2024) |
0.37% |
| Benchmark | FTSE All-Share Index |
| Overall Morningstar RatingTM As of 31/08/2024 |
|
| Morningstar Medalist RatingTM Effective 04/04/2024 |
|
| Analyst-Driven %: 100.00 Data Coverage %: 100.00 |
|
Source: BNP Paribas for holdings information and Morningstar for all other data. Differences in calculation may occur due to the methodology used.
Please note that the total voting rights in the Company do not include shares held in Treasury.
Marketing Communication
| Top 10 holdings | (%) |
|---|---|
| BAE Systems | 4.2 |
| Shell | 4.0 |
| Unilever | 4.0 |
| RELX | 3.9 |
| HSBC | 3.8 |
| AstraZeneca | 3.5 |
| British American Tobacco | 3.2 |
| Tesco | 3.0 |
| Imperial Brands | 2.7 |
| NatWest | 2.6 |
References made to individual securities do not constitute a recommendation to buy, sell or hold any security, investment strategy or market sector, and should not be assumed to be profitable. Janus Henderson Investors, its affiliated advisor, or its employees, may have a position in the securities mentioned.


The above geographical breakdown may not add up
to 100% due to rounding.



All performance, cumulative growth and annual growth data is sourced from Morningstar. Share price total return is calculated using mid-market share price with dividends reinvested.
Please remember that past performance does not predict future returns. The value of an investment and the income from it can rise as well as fall as a result of market and currency fluctuations, and you may not get back the amount originally invested. Please refer to the glossary for the definition of share price total return.
Technology 0.7% The above sector breakdown may not add up to 100% due to rounding.
| Stock code | CTY |
|---|---|
| AIC sector | AIC UK Equity Income |
| Benchmark | FTSE All-Share Index |
| Company type | Conventional (Ords) |
| Launch date | 1891 |
| Financial year | 30-Jun |
| Dividend payment | November, February, May, August |
| Management fee | 0.3% per annum of net assets |
| Performance fee | No |
| (See Annual Report & Key Information Document for more information) | |
| Regional focus | UK |
| Fund manager appointment |
Job Curtis 1991 David Smith 2021 |



Go to www.janushenderson.com/howtoinvest
Customer services 0800 832 832
The Bank of England (BoE) announced its first interest rate cut since the start of the COVID-19 pandemic in 2020, lowering its benchmark rate by 25 basis points to 5.0%.
The UK economy continued to grow and GDP was up 0.6% in the second quarter, following first-quarter growth of 0.7%.
Meanwhile, sterling hit a more than two-year high against the US dollar near the end of the month amid expectations that the US central bank, the Federal Reserve (Fed), would loosen monetary policy to a greater extent than the BoE in 2024.
The half-year financial results announced by companies were mainly satisfactory and the FTSE All-Share Index was up 0.5% in August.
The biggest positive contributor to relative performance was the underweight position in Shell compared to the FTSE All-Share Index. Shell's share price suffered from the fall in the oil price given weaker demand. The second biggest positive contributor was the holding in Tesco, the UK's leading food retailer, which we think has resilient profitability and strong cash flow.
The biggest detractor from performance relative to the index was the underweight position in AstraZeneca, the pharmaceutical company. AstraZeneca has a promising pipeline of drugs being developed but pays a relatively low dividend yield. The second biggest relative detractor was London Stock Exchange, which is not held in the portfolio.
In terms of trading activity, we made an addition to the holding in Aviva, which has been benefiting from rising profitability from its property and casualty insurance, as well as a strong cash flow from life insurance. We reduced the holding in 3i after a period of strong share price performance. 3i is an investor in private companies, including Action, a fast-growing discount retailer in Europe. We completely sold the position in Pennon, the water company, following further consideration of the tough draft determination from Ofwat, the water industry regulator.
Weaker global economic growth is leading to cuts in interest rates from central banks. We think the BoE might take a relatively cautious approach to future rate cuts, given the continuing high level of wage increases. Some two-thirds of revenues earned by companies that we invest in are from overseas, which provides useful diversification. However, there is considerable uncertainty for the global economy with ongoing elevated geopolitical tensions. Nonetheless, we think that the
valuation of UK equities is compelling compared to their equivalents overseas, possibly due to the low allocation from domestic, institutional investors. In particular, we find the dividend yield of UK equities attractive relative to the main alternatives.
Factsheet - at 31 August 2024
Marketing Communication

The amount by which the price per share of an investment company is either lower (at a discount) or higher (at a premium) than the net asset value per share (cum income), expressed as a percentage of the net asset value per share.
The effect of borrowing money for investment purposes (financial gearing). The amount a company can "gear" is the amount it can borrow in order to invest. Gearing is used in the expectation that the returns on the investments bought will exceed the costs of the borrowings that funded the purchase. This Company can also use synthetic gearing through derivatives and foreign exchange hedging and/or other non-fully funded instruments or techniques.
The Company's leverage is the sum of financial gearing and synthetic gearing. Details of the Company's leverage limits can be found in both the Key Information Document and Annual Report. Where a company utilises leverage, the profits and losses incurred by the company can be greater than those of a company that does not use leverage.
Share price multiplied by the number of shares in issue, excluding treasury shares, at month end. Shares typically priced mid-market at month-end closing.
The total value of a Company's assets less its liabilities.
The value of investments and cash, including current year revenue, less liabilities (prior charges such as loans, debenture stock and preference shares at fair value).
The value of investments and cash, excluding current year revenue, less liabilities (prior charges such as loans, debenture stock and preference shares at fair value).
The theoretical total return on shareholders' funds per share reflecting the change in Net Asset Value (NAV) assuming that dividends paid to shareholders were reinvested at NAV at the time the shares were quoted ex-dividend. A way of measuring investment management performance of investment trusts which is not affected by movements in discounts/premiums.
Total assets minus any liabilities such as bank loans or creditors.
A company's net exposure to cash/cash equivalents expressed as a percentage of shareholders' funds, after any offset against its gearing. This is only shown for companies that have gearing in place.
A company's total assets (less cash/cash equivalents) divided by shareholders' funds expressed as a percentage.
The total expenses for the financial year (excluding performance fee), divided by the average daily net assets, multiplied by 100.
Closing mid-market share price at month end.
The theoretical total return to the investor assuming that all dividends received were reinvested in the shares of the company at the time the shares were quoted ex-dividend. Transaction costs are not taken into account.
Cum Income NAV multiplied by the number of shares, plus prior charges at fair value.
Calculated by dividing the current financial year's dividends per share (this will include prospective dividends) by the current price per share, then multiplying by 100 to arrive at a percentage figure.
For a full list of terms please visit: https://www.janushenderson.com/en-gb/investor/glossary/

Overall Morningstar Rating™ is a measure of a fund's risk-adjusted return, relative to similar funds. Fund share classes are rated from 1 to 5 stars, with the best performers receiving 5 stars and the worst performers receiving a single star.
Overall Morningstar Rating™ is shown for an investment company achieving a rating of 4 or 5.
Morningstar Medalist Rating™
Ratings should not be taken as a recommendation. For more detailed information about Morningstar Ratings, including its methodology, please go to https://shareholders.morningstar.com/investor-relations/governance/Compliance--Disclosure/default.aspx.
Not for onward distribution. Before investing in an investment trust referred to in this document, you should satisfy yourself as to its suitability and the risks involved, you may wish to consult a financial adviser. This is a marketing communication. Please refer to the AIFMD Disclosure document and Annual Report of the AIF before making any final investment decisions. Past performance does not predict future returns. The value of an investment and the income from it can fall as well as rise and you may not get back the amount originally invested. Tax assumptions and reliefs depend upon an investor's particular circumstances and may change if those circumstances or the law change. Nothing in this document is intended to or should be construed as advice. This document is not a recommendation to sell or purchase any investment. It does not form part of any contract for the sale or purchase of any investment. We may record telephone calls for our mutual protection, to improve customer service and for regulatory record keeping purposes.
Issued in the UK by Janus Henderson Investors. Janus Henderson Investors is the name under which investment products and services are provided by Janus Henderson Investors International Limited (reg no. 3594615), Janus Henderson Investors UK Limited (reg. no. 906355), Janus Henderson Fund Management UK Limited (reg. no. 2678531), (each registered in England and Wales at 201 Bishopsgate, London EC2M 3AE and regulated by the Financial Conduct Authority), Tabula Investment Management Limited (reg. no. 11286661 at 6th Floor, 55 Strand London WC2N 5LR and regulated by the Financial Conduct Authority) and Janus Henderson Investors Europe S.A. (reg no. B22848 at 78, Avenue de la Liberté, L-1930 Luxembourg, Luxembourg and regulated by the Commission de Surveillance du Secteur Financier).
Janus Henderson is a trademark of Janus Henderson Group plc or one of its subsidiaries. © Janus Henderson Group plc
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.